首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TR AIL in pancreatic cancer cell
【24h】

The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TR AIL in pancreatic cancer cell

机译:TR AIL诱导胰腺癌细胞uPA,IL-8,MMP-7和MMP-9过表达的潜在分子机制

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND:TNF-related apoptosis-inducing ligand (TRAIL) is a death ligand of the TNF-superfamily that has been implicated in inducing apoptosis in some tumor cells. The purpose of this study was to ifnd out if TRAIL could induce the expression of uPA, IL-8, MMP-7 and MMP-9. and to explore the corresponding potential signaling transduction pathway in pancreatic cancer cells. METHODS:Colo357wt, Panc89 and PancTuⅠ cell lines were stimulated by TRAIL (100 ng/ml). Crystal violet cell vitality assay was used to check the sensitivity to TRAIL-induced apoptosis. Real-time RT-PCR tested the expression of uPA, IL-8, MMP-7 and MMP-9. RESULTS:TRAIL can stimulate the expression of uPA, IL-8, MMP-7 and MMP-9 in pancreatic cancer cell lines, especially in Colo357wt. The members of caspases, MEK1/2, PKC, and NF-κB are involved in TRAIL-induced expression of uPA, IL-8, MMP-7 and MMP-9. Furthermore, caspases play a different role in Colo357wt, Panc89 and PancTuⅠ. CONCLUSIONS:TRAIL-treatment may result in the enhancement of invasion involving the signaling pathways of caspases, MEK1/2, PKC and NF-κB, in pancreatic cancer cells. It points to the necessity to carefully evaluate in vivo side effects of TRAIL.
机译:背景:TNF相关的凋亡诱导配体(TRAIL)是TNF超家族的死亡配体,与某些肿瘤细胞的凋亡诱导有关。这项研究的目的是确定TRAIL是否可以诱导uPA,IL-8,MMP-7和MMP-9的表达。并探索胰腺癌细胞中潜在的信号转导途径。 方法:TRAIL(100 ng / ml)刺激Colo357wt,Panc89和PancTuⅠ细胞系。结晶紫细胞活力测定用于检查对TRAIL诱导的细胞凋亡的敏感性。实时RT-PCR检测了uPA,IL-8,MMP-7和MMP-9的表达。 结果:TRAIL可以刺激胰腺癌细胞系uPA,IL-8,MMP-7和MMP-9的表达,尤其是在Colo357wt中。胱天蛋白酶,MEK1 / 2,PKC和NF-κB的成员参与TRAIL诱导的uPA,IL-8,MMP-7和MMP-9的表达。此外,胱天蛋白酶在Colo357wt,Panc89和PancTuⅠ中起不同的作用。 结论:TRAIL治疗可能导致胰腺癌细胞中涉及胱天蛋白酶,MEK1 / 2,PKC和NF-κB信号通路的侵袭增强。它指出有必要仔细评估TRAIL的体内副作用。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2008年第002期|89-97|共9页
  • 作者单位

    Department of 0ncology, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;

    Molecular 0ncology Research Laboratory, Clinic for General and Thoracic Surgery, Christian-Albrechts-University, 24105 Kiel, Germany;

    Molecular 0ncology Research Laboratory, Clinic for General and Thoracic Surgery, Christian-Albrechts-University, 24105 Kiel, Germany;

    Department of 0ncology, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;

    Department of 0ncology, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;

    Molecular 0ncology Research Laboratory, Clinic for General and Thoracic Surgery, Christian-Albrechts-University, 24105 Kiel, Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:23
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号